press release
Published: 04 June 2024

New insights into T and B cells offer hope for autoimmune disease sufferers

Scientists should focus on the interactions between T and B cells to find better treatments for autoimmune disorders, such as rheumatoid arthritis, according to a new study from the University of Surrey.  

autoimmune disease

Systems Biology researchers have found that our metabolism could play an outsized role in the delicate balancing act between T and B cells, leading to autoimmune diseases. The study also found evidence that changes in metabolism caused by ageing add further risks.  

We have proposed a new way to treat autoimmune diseases by focusing on the metabolism of immune cells, like T and B cells. We can find more effective treatments by understanding how these cells interact to change their behaviour due to shifts in our body's energy processing.

This approach brings together different areas, such as inflammation and immunometabolism, how our immune system uses energy and the effects of ageing. Dr Matteo Barberis, Reader in Systems Biology, FHMS Coordinator of Centre for Mathematical and Computational Biology (CMCB), School International Lead

T and B cells are specialised white blood cells that play crucial roles in our immune system. T cells help identify and attack infected cells, while B cells create antibodies to neutralise harmful invaders like viruses and bacteria. Through mutual regulation, T and B cells can meet the metabolic demand required in each stage of their development. 

The team conducted a thorough critical analysis of the current literature in different areas, such as inflammation and immunometabolism, to comprehensively understand the processes involved, where metabolic, signalling and epigenetic routes integrate.  

This approach envisions therapeutic treatments of autoimmune disorders through a strategy of repurposing drugs capable of simultaneously targeting the immune system and the metabolism. It's a promising direction that could lead to better ways to manage conditions such as lupus or multiple sclerosis. Dr Matteo Barberis, Reader in Systems Biology, FHMS Coordinator of Centre for Mathematical and Computational Biology (CMCB), School International Lead

The study has been published in Clinical and Translational Medicine.  

Notes to editors 

Share what you've read?

Featured Academics

matteo barberis image

Dr Matteo Barberis

Reader in Systems Biology, FHMS Coordinator of Centre for Mathematical and Computational Biology (CMCB), School International Lead

Media Contacts

External Communications and PR team
Phone: +44 (0)1483 684380 / 688914 / 684378
Email: mediarelations@surrey.ac.uk
Out of hours: +44 (0)7773 479911